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Background: Multiple chronic condition is common in older adults with diabetes. 
Several prior studies have shown that having multiple chronic condition impact 
cardiometabolic risk factor controls (i.e., blood pressure, High-density lipoprotein (HDL) 
cholesterol level, and high glycated hemoglobin (HbA1c). However, it is not clear 
whether these results extend to a multiethnic sample of older adults. 
Objectives:  
1). Examine the association between Comorbidity profile and ABCs goals achievement. 
2). Examine whether the association between comorbidity profile and ABCs goals 
achievement is moderated by race/ethnicity.  
Methods: A sample of 3532 participants from Health and Retirement Study (HRS) years 
2010 and 2012 and corresponding HRS Biomarker data were included in this analysis. 
Individual without complete diabetes status and those with missing value of all outcome 
variables were excluded. The main outcome measures were three cardiometabolic risk 
factor controls (blood pressure control, glycated hemoglobin (HbA1c) control and HDL 
cholesterol control), which measured based on guideline-defined threshold. Explanatory 
variables were a participant’s comorbidity profile, characterized by the presence of 
specific chronic condition types (none, concordant only, discordant only, and both 
concordant and discordant). Analyses included logistic regression adjusted for survey 




Results: In the final study sample, (66%) were had both concordant and discordant 
condition, 19% were had only concordant condition, 9% were had only discordant 
condition, and only 6% were had no other chronic condition beside diabetes. We did not 
find significant associations between comorbidity profile and Blood pressure control (for 
concordant: OR: 0.9; 95% CI: (.05- 1.7), discordant: OR: 1.2; 95% CI: (0.6 – 2.1), and 
both condition: OR: 1.0; 95% CI: (0.6 – 1.8)). Diabetes patient with only discordant 
chronic condition or both concordant and discordant chronic condition were more likely 
to have HbA1c controlled than those with no chronic condition beside diabetes (for 
discordant: OR: 2.37; 95% CI: (1.30 – 4.33) and both condition: OR: 2.15; 95% CI: (1.18 
– 3.93). The association between HDL cholesterol and comorbidity profile were modified 
by race/ethnicity. Having concordant conditions was negatively associated with HDL 
cholesterol control among Hispanic (OR: 0.36; 95% CI; (0.14 – 0.92). The association 
was not significant among whites or blacks.  
Conclusions: This study shows that Comorbidity profile is associated with ABCs goals 
achievements among older adults with diabetes. Having discordant chronic conditions 
makes HbA1c goal achievement more likely. However, having concordant conditions 
makes HDL cholesterol goal achievement less likely: an effect that varies by 
race/ethnicity. Future study should further examine the association by using 
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Type 2 diabetes mellitus (T2DM) is the seventh leading cause of death in the 
United States 1. Aging is one of the risk factor for developing T2DM2. Approximately 
26% of older adults have diabetes2–4 and it is projected that, in 2050, the  prevalence of  
diabetes in older adults will increase by 4.5 fold3.  Recent studies estimated that 90% of 
older adult with diabetes have one or more comorbid condition 5 , and 40% have at least 
four or more conditions4–6. These multiple chronic conditions may impact diabetes care 
prioritization, health care utilization, and self-management ability5. Despite a dramatic 
improvement in diabetes treatment and quality of care, older adults with multiple chronic 
conditions are more likely to have uncontrolled of A1C, Blood pressure and Cholesterol 
level (ABCs goals) 7. Suboptimal ABCs goals were associated with a higher risk of 
diabetes related complications and mortality7–9.  
Improving diabetes care management may require greater attention to the type of 
comorbid chronic condition. Increasingly, studies are differentiating between concordant 
and discordant conditions6,10–14. Concordant conditions refer to “illnesses that overlap 
with diabetes in their pathogenesis and share care goals with diabetes (e.g., heart disease, 
hypertension, stroke)6.” Discordant conditions are “illnesses with unrelated pathogenesis 
to diabetes or that do not share care goals or underlying predisposing factors with 
diabetes (e.g., mental health illnesses, cancer, arthritis)6.”  There is some evidence to 
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suggests that among older adults with diabetes, concordant conditions are associated with 
better diabetes care outcomes 6,12,13 and discordant conditions are  associated with poorer 
diabetes care outcomes 10–12,15. However, most of these studies did not include diverse 
racial/ethnic populations or the study had a crude measure of race/ethnicity (i.e., white 
versus non-white). 
Racial disparities in ABCs goals achievement among older adult with diabetes 
have been documented 7,16,17. For example, African Americans and Hispanics with 
diabetes typically have worse control of ABCs goals than whites16. Although several 
explanations for observed racial/ethnic disparities are attributed to lower socioeconomic 
status,  inadequate health care access, poorer visit time management, fewer interactions 
with the health care system, few studies have examined whether differences in 
comorbidity profile can help further explain the observed differences18. A study by 
Pentakota, found that discordant conditions are observed to be high in non-white groups, 
but their effect on the racial disparity in ABCs goals achievement is not well 
investigated12.  Over all the role of comorbidity profiles in racial/ethnic disparities in 
diabetes outcomes remains unclear. To address these gaps, we propose to use data from 
the Health and Retirement Study (waves 2010 and 2012), to examine the association 
between comorbid chronic condition profile on ABCs goals achievement among a 





Diabetes Burden and Public Health Significance  
Type 2 diabetes mellitus (T2DM) is the seventh leading cause of death in the 
United States 1. Aging is one of the risk factor for developing T2DM2. Approximately 
26% of older adults have diabetes2–4 and it is projected to increase by 4.5 fold that, in 
20503.  Complications due to diabetes is a major cause of disability, reduced quality of 
life and death among older5,8,19. A study by Caspersen et.al20 reported that diabetes can 
result in  8 years reduction in life expectancy among people aged 55 to 64. This  means a 
57 years old diabetic person may have an equivalent biological age to that of a 65 years 
old person without diabetes20. The study by Kalyani et.al8 also demonstrated that  older 
adults with diabetes have a high prevalence of disabilities than older adult  without 
diabetes.  More than 50% of older adult with diabetes reported difficulty performing daily 
physical tasks21. Diabetes imposes a profound economic cost in the health care system 
due to routine care for it and hospital care to treat diabetes related complications. For 
example, diabetes care accounts for a total of $245 billion every year, out of this $176 
billion is direct medical costs and the remaining $69 billion is for indirect cost due to 
disability, work loss and premature death2.
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Cardiometabolic risk factor control among older adults with diabetes  
Diabetes patient with optimal ABCs goals are associated with a reduction in risk 
of diabetes related complications 7,19,22. Results in a study by Stratton et.al.23 found that a 
1% reduction in HbA1c was associated with reductions in diabetes related outcomes - 
21% in deaths related to diabetes, 14% in myocardial infarction, and 37%  in 
microvascular complications 23. In another study, similar results were found among older 
adults with diabetes who achieved blood pressure control goal - 32 % reduction in death 
related to diabetes, 44%  in stroke, and 37% in micro- vascular disease24. Currently, the 
American Diabetes Association recommends control goals for adults with diabetes which 
includes:- HbA1c<7.5%, BP <140/90mmHg, and LDL cholesterol <100 mg/dL25. 
However, most older adult with diabetes are unable to achieve the clinical guideline goals 
for controlling cardiometabolic risk factors such as blood pressure and cholesterol7,26. A 
study by Casagrande et.al 7 found that 80% of people with diabetes did not achieve  
ABCs goals and the prevalence of achieving blood pressure(BP) < 130/80 mmHg 
decreased with increasing age. Findings suggest that, to achieve a better outcome and 
reduce diabetes related complications, diabetes care quality should focus and integrate on 
ABCs goals achievement, treatments and prevention. 
Racial/ethnic differences in the prevalence of diabetes are well documented2,27 . 
Blacks and Hispanics experience a two times higher burden of diabetes. According to 
previous studies, non-Hispanics blacks (13.2%) and Hispanics (12.8%) have higher 
prevalence in comparison to non-Hispanic whites (6%)2. Due to this higher burden of 
diabetes, blacks and Hispanics are disproportionately affected by diabetes related 
complications, which may in part be explained by poorer ABCs goals achivements18. For 
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example, glycemic control is lower among Hispanics and blacks (35% and 37% 
respectively) compared to whites (49%)28. Improving cardiometabolic risk factor control 
among blacks and Hispanics may help to reduce the racial disparities in diabetes 
outcomes. Differences in access to health care, diabetes prevention and control programs, 
socioeconomic status, and neighborhood context are factors that help to explain some of 
the variations observed in ABCs goals achivements16,28.However, a limited number of 
studies have explored the role of multiple chronic conditions  as a key factor in 
contributing to disparities. 
Multiple chronic conditions and burden in older adults with type 2 diabetes mellitus 
In the United States, multimorbidity (or multiple chronic conditions), the presence 
of two or more co-occurring chronic conditions, is common and one-third of the older 
population is affected by it29. Several different approaches have been used to examine 
multimorbidity. The most common way is to sum the total number of chronic 
conditions6,30.  However, there is no consensus regarding the number of conditions that 
should be included.  The type and number of conditions may depend on the data source 
that is used. For example, studies that are using medical records can include about 5-62 
conditions11,30. On the other hand, studies that have used nationally representative 
population-based datasets that rely on self-reports such as the National Health and 
Nutrition Examination Survey (NHANES), Behavioral Risk Factor Surveillance Study 




Multiple chronic conditions and type 2 diabetes mellitus  
Multiple chronic conditions are common in older adult with diabetes. Studies by 
Guneir et.al5 estimates that 90% of older adults with diabetes have one or more chronic 
conditions, and 40% have five or more conditions 5. Having multiple chronic conditions 
can impact the quality of life and health care utilization5 . For example, emergency visits 
and hospitalizations were four times higher among older adults with five  or more 
comorbid conditions compared to those without chronic conditions5. In addition, multiple 
chronic conditions are associated with less engagement in diabetes self-management 
activities 6,10. For example, the presence of cancer or arthritis may eclipse the priority of 
diabetes care and make its self-management much more difficult.  
There is a lack of evidence-based guidelines to care for type 2 diabetes mellitus 
patients with  specific disease clusters32,33. To our knowledge, there is no clear guidance 
in placed on how to manage, integrate and prioritize care for multiple chronic conditions 
and  only little is known how diabetes management affected by the presence of comorbid 
conditions31,32,34. To achieve better health outcomes among diabetes patients with 
multiple chronic conditions, furthering our understanding of the types of multiple chronic 
conditions may improve diabetes management outcomes.  
Piette and Kerr6 discusses how multimorbidity profiles may have a great impact 
on diabetes care outcomes. In their typologies for comorbid chronic conditions, they 
suggested to classify chronic condition based on their characteristic 
(concordant/discordant). Concordant conditions are those that have related management 
and pathogenesis with diabetes e.g. hypertension heart failure and cerebrovascular 
diseases. When the condition is concordant the provider may be able to provide more 
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integrative and synergistic care. Discordant conditions are those have unrelated 
management and pathogenesis with diabetes e.g. arthritis and cancer. In the presence of 
discordant conditions, it is difficult for providers to integrate care and may also encounter 
drug-drug interactions34.  
Data from a limited number of studies support this concepts 6,12,13, For example, a 
retrospective cohort study by Pentakota et.al12 examined veterans with new onset of 
diabetes to evaluate the relationship between diabetes care and the type of comorbidity 
(i.e. whether comorbidities were discordant or concordant). In this study, diabetes care 
was measured by number of visits per year (face to face visit), level of HbAc1 and LDL 
cholesterol. The findings suggested that patients with concordant conditions had better or 
similar quality of cares (Magnan et.al). For example, the odds of getting tested for HbA1c 
as per guideline is 17% higher in patients with concordant condition compered to patient 
with no comorbidity (OR: 1.17; 95%CI: (1.09 -1.25) ; whereas, patients with discordant 
conditions had poorer quality of care (the discordant group had 12% lower odds of 
meeting the guideline)12. Another study found inconsistence  care response for diabetes 
with discordant condition, observed  both better and worse diabetes cares13. However, the 
study has limitations, first the study excluded patients with limited life expectancy or 
terminal conditions (e.g metastatic cancer) that limited examination of the impact of total 
number of discordant condition including serious conditions that might have a greater 
impact on diabetes care. Second, the study was conducted in the VA, which serves 
mainly male elderly patients population, and had limitation on its generalizability. The 
other study also used data from a Midwest population that is not racially diverse as 
general population.  The present study proposed to use data from HRS that is as racially 
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diverse as the general us population, which offers an excellent opportunity to examine 
racial/ethnic disparity in diabetes care.





Study Aim  
The main aim of this study was to examine the association between chronic 
condition profiles on ABCs goals achievement among a diverse sample of older adults 
with type 2 diabetes mellitus. Specifically, the objective was to analyze the association 
between comorbidity profile type and ABCs goals achievement by race/ethnicity among 
older adults with type 2 diabetes. 
Study design  
This study is a cross- sectional study design employing data from the Health and 
Retirement Study (HRS).  
Data Source  
Data from Health and Retirement Study (HRS), year 2010 and 2012 database 
were used for this study. More specifically we combined data from the core interviews, 
the biomarker dataset, and the RAND HRS datafiles (cleaned, processed, and streamlined 
collection of variables from HRS). HRS is biennial longitudinal panel survey that is 
nationally representative of Americans age 50 and older. The HRS over-samples 
Hispanic and Black individuals and sampling weights are provided. Interview is 
conducted every two years by telephone or in person. The study is funded by the National 
Institute of Aging and conducted by the Institute for Social Research at the University of 
Michigan. Detail about the study can be found in (http://hrsonline.isr.umich.edu/).
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Study Population  
Our sample was limited to individuals who have type 2 diabetes mellitus. 
Participants included in this study are those who have been told by a doctor that they had 
the disease. If participant reports not having diabetes at the time of interview, they were 
consider not having diabetes and were exclude from this study (n= 11,311).  Individuals 
who were missing all three outcome variables (blood pressure, HbA1c and LDL 
cholesterol; n= 3) were excluded. In addition, individual who were self-reported 
race/ethnicity as other or missing race/ethnicity variable (n=142) were excluded yielding 
analytic samples of 3567 individuals.  
Definition of variables   
Dependent variable  
This study assessed three outcome variables: HbA1c, HDL and blood pressure. 
HDL and HbA1c was collected using dried bold spot technique. In 2010 wave, the 
Heritage Laboratory was used to assay total cholesterol and HbA1c. In 2012 wave, the 
University of Washington was used to assay both total cholesterol and HbA1c level36.  
Blood pressure was measured by using an automated device that has been 
validated against manual measurement36. The measurement was taken from the 
respondent’s left arm and data recorded for systolic and diastolic pressure. Respondents 
were instructed to sit down with both feet on the floor and their left arm comfortably 
supported with the palm facing up. Then cuff was adjusted approximately half an inch 
above the elbow and made direct contact with the skin. Three measurements were taken 
at different time. The average of the three measurements were used for the analysis.   
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Although these three variables are continuous, we categorized them as a 
dichotomous variable.  The cutoff point was based on American Diabetes Association 
guideline-recommended diabetes control care goals and guidelines for improving the care 
of the older person with diabetes mellitus25,37 : HbA1c: > 7.5% = uncontrolled; HDL 
level: for female < 40 mg/dl and male < 50 mg/dl = uncontrolled; BP level: diastolic/ 
systolic greater than 140/90 mmHg. These three variables reflect how well 
cardiometabolic risk factor control was achieved.   
Independent variable  
Multimorbidity were assessed based on a total of 8 chronic conditions 
(hypertension, cancer, chronic lung disease, heart disease, stroke, Alzheimer’s/dementia, 
psychiatric problems, and arthritis) collected in HRS. In HRS each condition was 
measured by asking the respondents whether the doctor has ever told him/her has the 
condition.  
Cancer: was assessed by asking: “Has a doctor ever told you that you had a 
cancer or a malignant tumor, excluding minor skin cancer?”  
Chronic lung disease: was assessed by asking: “Has a doctor ever told you that 
you had chronic lung disease such as chronic bronchitis or emphysema?” 
Heart disease: was assessed by asking: “Has a doctor ever told you that you had 
a heart attack, coronary heart disease, Angina, congestive heart failure, or other 
heart problems?”  




Stroke: was assessed by asking: “Has a doctor ever told you that you have a 
stroke?  
Arthritis: was assessed by asking: “Has a doctor ever told you that you had 
arthritis or rheumatism?”  
Alzheimer’s/Dementia: was assessed by asking: “Has a doctor ever told you that 
you had Alzheimer disease or dementia.?”  
Psychiatric problem: was assessed by asking: “Has a doctor ever told you that 
you had emotional, nervous, or psychiatric problems?”  
Concordant conditions included hypertension, heart disease, and stroke. 
Discordant conditions included: cancer, psychiatric problems, chronic lung disease, 
arthritis, and Alzheimer’s disease. Based on previous research12,38, participants was 
grouped into the  following categories: none chronic conditions; concordant only; 
discordant only; concordant and discordant conditions.  
Effect modifier 
Race/ethnicity: was assessed by two different questions. Respondents were asked: 
“Do you consider yourself primarily White or Caucasian, Black or African America, 
American Indian, or Asian, or something else” and grouped into three different 
classification: white or Caucasian, Black or African American and other.  Second, they 
were asked: “Do you consider yourself Hispanic or Latino?”. Single variable for 
race/ethnicity was created based on the responses to the two questions. Then participant 
was assigned in to three mutually exclusive categories (Non-Hispanic White, Non-
Hispanic Black and Hispanic). Those participants reported other or have missing value 




Based on prior studies6,12,13 the following variables was included as confounders: 
age, sex educational level, marital status, health insurance status, number of hospital visit, 
self-rated health status, diabetic medication type (oral vs insulin), hypertension 
medication, and physical activity. The same question was asked in 2010 and 2012 wave 
and the variable was a result of both waves. 
Age: collected as a continuous variable and utilized as continuous variable in this 
study 
Sex:  was used the same way categorized in the data set female and male 
Educational level: education was measured by the years of education from 0 to 17 
that the participant had finished and categorized as 1 = less than high school, 2 = high 
school graduate/GED, 3 = some college, and 4 = college and above.5. In the percent 
study education status, were measured by three categories, “less than high school”, “high 
school” and “some college or above”.  
Marital Status: were coded married if respondents report “married” and unmarried 
if they report “single”, “never married”, “divorced”, “widowed”, and “separated”. If the 
response was “other”, “don’t know”, “refused”, or blank it was coded as missing.  
Self-rated health status: Participant were asked “Would you say your health is 
excellent, very good, good, fair, or poor?” Answer options ranged from 1 (excellent) to 5 
(poor). In the percent study, participant was grouped based on their response: excellent or 




Diabetic medication type (oral vs insulin): this variable was created by combining 
a response from two different questions, “Do you now use insulin?” and “Do you 
currently take any diabetes medication that you take by mouth?” For both question the 
response variable is “yes”, “no” or “Don’t know”. Participant was grouped in to four 
groups based on their answer: oral medication, insulin, both, and neither.  
BMI: calculated from weight divided by square height. Participants provided their 
weight in pounds and converted to kilogram in the BMI calculation. The same way 
participant asked about their height in feet and inches and converted to meters for BMI 
calculation. BMI is continuous variable and was categorized in to three groups: 
Under/Normal weight (<25 kg/m2); Over weight (25 kg/m2 to 30 kg/m2); Obese (>=30 
kg/m2).  
Physical activity: was assessed by asking three questions; "We would like to 
know the type and amount of physical activity involved in your daily life? How often do 
you take part in sports or activities that are vigorous, moderate or light physical activity?” 
The possible responses included every day, more than once per week, once per week, one 
to three times per month, or never. For the present study participant was dichotomized 
into “Physically active” if the participant answer, every day, more than once per week, 
once per week in one of the three physical activities, and “not physically active “if the 
participant answer one to three times per month, or never in all three activities that is 
intensive, moderate and light physical activities.  
Health insurance status: was assessed by asking three different questions which 
included, “Are you currently covered by Medicare health insurance?”; “Are you currently 
covered by (Medicaid/STATE NAME FOR MEDICAID)?”; “We’d like to ask about all 
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the other types of health insurance plans you might have, such as insurance through an 
employer or a business, coverage for retirees, or health insurance you buy for yourself, 
including Medigap or) other supplemental coverage. If the participant answer was yes for 
one of the above question they were categorized as insured and if their answer was no 
they was categorized as uninsured. 
Doctor Visit: participant asked to report number of doctor visit in the last two 
years and it was collected as a continuous variable and recoded as a categorical variable. 
Based on the previous literature the participant was grouped 12 into four groups <7, 7-
12,13-24 and >24 visits per year. 
Medication for blood pressure:  participants were asked to report if they are taking 
any medication to lower their blood pressure.” To lower your blood pressure, are you 
now taking any medication?”. The response variables are “yes”, “no” or “Don’t know”. 
Participant were grouped in to two groups based on their answer: “Yes” or “no”. If a 
Participant respond was “don’t know” it was coded as missing.   
Statistical Analysis  
All analyses were conducted using SAS version 9.4 software. Descriptive analysis 
was used to assess all study variables by comorbidity profiles. For continuous variable 
means and standard deviation were reported and for categorical variable percentages and 
frequencies were reported. To test for significant differences between groups we used t-
test (for continuous variables) and chi-square test (for categorical variables).  
 We used logistic regression analyses to examine the association between 
comorbidity type and each dependent variable: HbAlc, BP and HDL. Three different 
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logistic regression models were constructed regardless of the ABCs goal variable being 
analyzed: 
Model 1: unadjusted model, it only had comorbidity type and adjusted for wave. 
Model 2: model 1 + additionally adjusted for demographic characteristics (age, 
educational level, marital status, income, health insurance status). 
Model 3: Model 2 +additionally adjusted for self-rated health status, diabetes 
medication type, BMI, physical activity, and number of doctor visits.  
Model 4: Model 3 +, additionally adjusted for interaction term between 
comorbidity profile and race/ethnicity. The sample was divided in the basis of 
race/ethnicity and model 3 was fit and multiple logistic regression was performed.  
Sensitivity Analysis 
1. To examine whether there is a systematic difference in the distribution of 
study variables between 2010 and 2012 year. The frequency of each study variable was 
compared (Table A.1). Over-all there were no systematic difference in the distribution of 
the study variables between 2010 and 2012 years, however, few variables show 
significant difference. The average age was significantly differed (2010: 68.9; 2012:  
67.9; p-value = .0024). We observe significant difference in the distribution of diastolic 
blood pressure (2010: 79.2mmHg; 2012: 78.0mmHg; P-value = 0.004) and systolic blood 
pressure (2010: 133.7mmHg; 2012: 131.8; P-value = 0.007). Considering these results, 
we adjusted for survey year in the analysis. 
2. To assess the association between the number of concordant or discordant 
chronic conditions and ABCs goals achievement (Table A.2). We categorized the number 
of chronic conditions in to three different groups: 0, 1-2, 3+ conditions for both 
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concordant and discordant separately. There were no significant associations between 
ABCs goals achievement and number of concordant chronic condition. Similarly, there 
were no significant associations between HDL control and number of discordant chronic 
conditions. However, having 1-2 or 3+ numbers of discordant chronic condition were 
associated with greater odds of achieving HbA1c control (OR: 1.35; 95% CI: 1.08 – 1.69; 
OR: 1.75; 95% CI: (1.21 – 2.53) respectively), than no having any discordant chronic 
condition. Individuals with 3+ numbers of discordant chronic condition were more likely 
to have blood pressure control (OR: 1.73; 95% CI: (1.07 – 2.80) than individuals who 
have no chronic condition. No other significant difference was noted. 
3. To assess whether the association between comorbidity profile and HbA1c 
control would change if HbA1c level was categorized based on different cut point = 
8.0mmol/mol (Table A.4) A guidelines of American Diabetes Association (ADA) 
recommend a cut point for HbA1c of 8.0mmol/mol for older adults with complex 
multiple coexisting chronic condition, high treatment burden and shorter remaining life 
expectancy. In other hand, older adults with longer remaining life expectancy and fewer 
coexisting chronic condition can use a cut point of 7.5mmol/mol, which was used for our 
main analysis. The result from a cut point 8.0mmol/mol, found no significant association 
between comorbidity profile and HbA1c control. This result is different from the result 
form main analysis (cut point 7.5mmol/mol). This result discussed in the result section.   
4. To assess whether the association between comorbidity type and blood 
pressure control would change if blood pressure level was categorized based on different 
cut point = 130mmHg systolic and 80mmHg diastolic (Table.A.3). For cut points 
130/80mmHg, there were no significant association between blood pressure control and 
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Descriptive Analysis  
Our sample has 3532 individuals with diabetes. The highest proportion of sample 
(66%) had both concordant and discordant condition besides diabetes. About 19% of 
sample had only concordant condition, 9% had only discordant condition, and only 6% of 
them were free of other chronic condition except diabetes (Table 4.3).  
Sociodemographic characteristics by comorbidity types are presented in Table 
4.1. Almost all variables were significantly associated with comorbidity profiles (P- 
value<.05). The sample average age was 67 years old and composed of 52% female, 72% 
white and 61% married. Individuals with both concordant and discordant chronic 
condition were significantly older (68 years) than individual with no chronic condition 
(62 years) (p-value = <0.0001). The percentage of non-Hispanic white was significantly 
higher among group who have only discordant chronic conditions (81%) or both 
concordant and discordant chronic condition (74%) than group with no chronic condition 
(66%). Among the group with both chronic condition, 55% were females, 74% were 
whites, 57% were married and 61% were physically inactive. Obesity is slightly higher 
among the group with both chronic condition than the group with only concordant or with 
only discordant chronic conditions. The prevalence of blood pressure medication intake 
was disproportionately higher in individuals with only concordant chronic conditions 
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(85%) and individual with both discordant and concordant (86%) chronic conditions 
compered to individuals with only discordant chronic condition (5%). 
Table 4.2 illustrated the percentage of those who achieved their ABCs goals. For 
the HbA1c goal, approximately, 79% of the sample met the HbA1c target of less than 
7.5mmol/mol. When we look by comorbidity profile, 67% of those who have no chronic 
conditions, 77 % of those who have only concordant chronic conditions, 84% of those 
who have only discordant chronic conditions and 80% of those who have both chronic 
conditions met the HbA1c target of less than 7.5mmol/mol. On the other hand, slightly 
over half (58%) of the sample met HDL cholesterol target of < 40 mg/dl for female and < 
50 mg/dl for male.  When we look HDL cholesterol level control 68% of those with no 
chronic condition beside diabetes, 62% of those who have only concordant chronic 
conditions, 66% of those who have only discordant chronic conditions and 55% of those 
who have both chronic conditions were achieved HDL cholesterol goal. Only 32 % of the 
sample met all three ABCs goals (cholesterol, blood pressure and HbA1c) together. 
When we look by comorbidity profile 43% of those who have only discordant condition 
achieved all three targets. Among those who have only concordant chronic condition 
32% of those achieved all three targets. Among those who have both chronic condition 
30% of those achieved all three targets.  
Table 4.3 illustrated the prevalence of comorbidity profile by race/ethnicity. The 
proportion of having only concordant chronic conditions were greater among blacks 
(20%) than whites (17%) however, proportion of having only discordant chronic 
conditions were smaller among blacks (4%) than whites (10%). Proportion of having 
both concordant and discordant chronic conditions were greater among blacks (71%) than 
 
21 
whites (68%). Proportion of having only concordant chronic conditions were highest 
among blacks (20%) comparing to Hispanics (13%) and whites (17%). The Proportion of 
having both concordant and discordant chronic conditions were smaller among Hispanics 
(55%) than whites (71%) and blacks (68%).    
Statistical Analysis  
The results from unadjusted and adjusted logistic regression model for each 
cardiometabolic risk factor control was presented in table 4.4.   
HbA1c models: When only adjusting for survey year (model 1)   having only 
concordant, only discordant, or both chronic conditions were  associated with 
significantly increased odds of HbA1c control compared to having no chronic conditions, 
(for concordant: OR: 1.61; 95% CI: (1.05-2.47), discordant: OR:2.54; 95% CI: (1.42 – 
4.53), and both condition: OR: 1.97; 95% CI: (1.28 – 3.03)). Similarly after adjusting for 
socio-demographic variables, having only concordant chronic conditions, only discordant 
chronic conditions, or both chronic conditions were associated with significantly 
increased odds of  HbA1c control, (for concordant: OR: 1.66; 95% CI: (1.13 - 2.45), 
discordant: OR:2.11; 95% CI: (1.22 – 3.64), and both condition: OR: 1.61;  95% CI: 
(1.08 – 2.40)). Finally, after adjusting for clinical factors and lifestyle characteristic 
variables the association was slightly higher and remained significant (for concordant: 
OR: 1.88; 95% CI:(1.08 – 3.27), discordant: OR: 2.37; 95% CI: (1.30 – 4.33), and both 
condition: OR: 2.15; 95% CI: (1.18 – 3.93). An interaction term between race/ethnicity 




 HDL Cholesterol model. When only adjusting for survey year, having both 
(concordant and discordant) chronic conditions were negatively associated with HDL 
control (OR: 0.58; 95% CI:( 0.41 – 0.82). However, having only concordant or only 
discordant chronic conditions were not significantly associated with HDL cholesterol 
control. After controlling for socio-demographic variable, the result was remained the 
same, having both (concordant and discordant) chronic conditions were less likely to 
achieving HDL control comparing to those with no chronic conditions (OR: 0.7; 95% CI: 
(0.49 - 0.99).  However, after adjusting for clinical factors and lifestyle characteristic 
variables there were no significant association noted between chronic condition profiles 
and HDL control. Lastly, by using fully adjusted model, race/ethnicity was assessed as 
modifiers of the association between HDL control and comorbidity profiles. The 
interaction between race/ethnicity and comorbidity profile were significant (p-value 
=0.03). Table 5 illustrates the association between comorbidity type and HDL control 
level by race/ethnicity.  For white and black no association was observed between 
comorbidity profile and HDL cholesterol control. Similarly, there were no significant 
association between having discordant or both (concordant and discordant) chronic 
conditions and HDL cholesterol control among Hispanics. However, Hispanics with 
concordant chronic conditions were less likely to control their HDL cholesterol level than 
those Hispanic with no chronic condition beside diabetes (OR: 0.39; 95% CI: (0.16 – 
0.95).  
Blood pressure model.  For all three model (model 1, model 2 and model 3) 
there were no significant associations between blood pressure control and comorbidity 
profiles.  Interaction term between race/ethnicity and comorbidity profile was assessed in 
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fully adjusted model as modifiers of the association between blood pressure control and 
comorbidity profiles however, it was not significant (P = 0.28).  
All ABCs Target Model.  For model 1(unadjusted model) and model 2 (after 
adjusting for socio-demographic variables) we found no significant association between 
comorbidity profile and all three targets achievements. In model 3, having only 
discordant, or both chronic conditions were associated with significantly increased odd of 
controlling all three targets compared to having no chronic conditions, (for discordant: 
OR: 2.07; 95% CI: (1.15 – 3.70), and both condition: OR: 2.05;95% CI: (1.16 – 3.62)) 
(Table 4.6).  
Table 4.7 illustrated a detail of results from the final adjusted model. After 
adjusting for all covariates. Sex was associated with HDL control, compared to females, 
males were significantly more likely to have a higher odd of HDL control (OR: 2.54; 
95% CI: (2.02 – 3.20). Age, marital status, education, health insurance, physical activity, 
face to face doctor visit and taking blood pressure medication were not significantly 
associated with HDL cholesterol control. Blacks were significantly more likely to control 
their HDL cholesterol level compared to whites (OR: 1.63; 95% CI:(1.26 – 2.13). 
Similarly, Hispanics have a higher odds of HDL control compared to whites, it was 
marginally significant (OR:1.33; 95% CI: (1.03 – 1.70).  Individuals who intake oral 
diabetes medication or those who intake both oral and insulin diabetes medications were 
less likely to control their HDL cholesterol level compared to those with no diabetes 
medication (OR:0.54; 95% CI: (0.36 - 0.84) and OR: 0.60; 95% CI: (0.43 - 0.80) 
respectively. Similarly, individual with poor self-rate health status less likely to control 
their HDL cholesterol level compared to those with good self-rate health status (OR: 
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0.78; 95% CI: (0.63 – 0.96). Overweight or obese were related to lower odds of HDL 
cholesterol control compared to normal weight (OR: 0.64; 95% CI: (0.52 - 0.82) and OR: 
0.54; 95% CI: = (0.40 - 0.37) respectively.  
Blacks were significantly less likely to control their HbA1c level compared to 
whites (OR: 0.67; 95% CI: (0.46 - 0.98).  Sex, age, marital status, BMI, self-rate health 
status, education, health insurance, physical activity and face to face doctor visit were not 
significantly associated with HbA1c control. Individual who take any kind of diabetes 
medication were less likely to control their HbA1c level compared to those who do not 
take any diabetes medication. In other hand individual with poor self-rate health status 
less likely to control their HbA1c level compared to those with good self-rate health 
status (OR: 0.74; 95% CI:(0.56 – 0.96). Individual with high school diploma were less 
likely to control their blood pressure level compared to individual with some college 
degree or higher education status (OR:0.71; 95% CI: (0.54 - 0.95). Like HbA1c control, 
blacks were significantly less likely to control their blood pressure compared to whites 
(OR:0.58; 95% CI: (0.44 – 0.77). Hispanics were less likely to control their HbA1c level 
compared to whites, (OR:0.71; 95% CI:(0.53 – 0.93). Finally, sex, marital status, BMI, 
self-rate health status, health insurance, physical activity, diabetes medication intake, and 


















  % %,  % p-value a %  p-value b % p-value c 
Age (Mean) years 67.3 62 64 <0.001 65 <0.001 68 <0.001 
Sex (%)         
       Female 52 46 39 0.15 55 0.14 55 0.09 
       Male 48 54 61  45  45  
Race/ethnicity (%)         
        Non-Hispanic White 72 66 66 0.64 81 0.0007 74 0.0005 
        Non-Hispanic black 14 12 15  6  15  
        Hispanic 14 22 19  13  11  
Marital status (%)         
         Married 61 70 65 0.46 72 0.74 57 0.02 
         Not married 40 30 35  28  43  





        Active  45 63 49 0.002 62 0.79 39 <.0001 
        Not active  55 37 51  38  61  
Total face to face visits (%)         
       <7 per 2 years 54 80.5 69 0.06 59 <.0001 46 <.0001 
      7 -12 per 2 years 24 13 19  22  27  
      13-24 per 2 years 2 0.5 2  2  3  
      24+ per 2 years 20 6 11  17  24  
Diabetes medication (%)         
       Oral 55 56 63 0.01 49 0.04 54 0.007 
       Insulin        8 10 5  6  9  
       Both 13 5 10  10  15  
      Non 24 29 22  35  22  
BMI (%)         
    Normal 15 30 17 0.0029 20 0.11 13 <.0001 
    Over weight 31 31 35  36  29  





Self-rate health status (%)         
      Poor 51 27 39 0.03 33 0.3 58 <.0001 
     Good 49 73 61  67  42  
Health insurance (%)         
       Insured 93 88 86 0.6 96 0.03 95 0.03 
      Uninsured 7 11 14  4  5  
Education (%)         
        <high school 27 20 23  21  29  
       High school 28 19 28 0.09 26 0.34 30 <.0001 
    >some college 45 61 29  53  41  
Blood pressure medication (%)         
       Yes 74 1 85 <.0001 5 0.19 86 <.0001 
       No 26 99 14  97  14  
 a. P-value represents the comparison of variables between individuals who do have concordant chronic condition and those who do not have 
chronic condition except diabetes; b. P-value represents the comparison of variables between individuals who do have discordant chronic 
condition and those who do not have chronic condition except diabetes; c. p-value represents the comparison of variables between individuals 
who do have both concordant and discordant chronic condition and those who do not have chronic condition except diabetes; d. Bold font 
represents a significant p-value.; e. HRS consider weighted percentage in account  
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Table 4.2. Percentage of participant who achieved each ABCs goal by comorbidity 























64 (33) 178 (23) 53 (16) 494 (20) 









62 (32) 259 (38) 90 (34) 1067 (45) 









54 (29) 257 (36) 57 (23) 827 (31) 









124 (67) 467 (68) 156 (57) 1705 (70) 
 
a. HbA1c control <7.5 mmol/mol 
b. HDL control for female <50 mg/dL and for male < 40 mg/dL 




Table 4.3. Distribution of comorbidity profiles by race/ethnicity, Health and Retirement 










Hispanic, N (%) White, N (%) 
Concordant 657 (19) 176 (20) 170 (13) 311 (17) 
Discordant 266 (9) 37 (4) 53 (8) 176 (10) 
Both 2424 (66) 618 (71) 358 (55) 1448 (68) 






Table 4.4. Crude and adjusted association between comorbidity profiles and each ABCs goal achievement, Health and Retirement 




HDL Cholesterol HbAc1 Blood Pressure 
Type 
Model 1a Model 2b Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
OR 
 (95% CI) 
OR 
 (95% CI) 
OR 
 (95% CI) 
OR 













(0.50 – 1.16) 
0.71  




(1.05 – 2.47) 
1.6 6 




 (0.4 – 1.3) 
0.8  
(0.4 – 1.4) 
0.9  
(0.5 – 1.7) 
Discordant  
0.91  
(0.58 – 1.41) 
1.00 




(1.42 – 4.53) 
2.11 




(0.7 – 2.4) 
1.3  
(0.7 – 2.4) 
1.2  
(0.6 – 2.1) 
Both 
0.58  
(0.41 – 0.82) 
0.62  




(1.28 – 3.03)  
1.61  
(1.08 – 2.40) 
2.15 
(1.18 – .93)  
0.89  
(0.5 – 1.4) 
1.0 
(0.6 – 1.6) 
1.0 
(0.6 – 1.8) 
Noned 1 1 1 1 1 1 1 1 1 
 
a. Model 1: Unadjusted model 
b.  Model 2: Model 1 and additionally adjusted for Socio-demographic covariates: -  age, gender, race/ethnicity, marital status, education status, health-insurance  
c. Model 3: model 2 and additionally adjusted for BMI, self-rated health, physical activity, smoking status, medication for hypertension, medication for diabetes, 
face to face doctor visits 
d. Reference group 




Table 4.5. Adjusted association between comorbidity profiles and HDL control by race, 





Non-Hispanic white Non-Hispanic black 
 
Hispanic 
OR (95% CI) OR (95% CI) OR (95%CI) 
Concordant  1.63 0.85 – 3.14 0.44 0.11 – 1.76 0.39 0.16 – 0.95 
Discordant  1.76  0.89 – 3.48 0.71 0.19 – 2.69 0.80  0.26 – 2.43 
Both  1.48 0.80 – 2.75 0.50 0.15 – 1.63 0.51 0.23 – 1.13 





a.  Adjusted for wave, comorbid condition, age, gender, race/ethnicity, marital status, education status, 
health insurance, BMI, self-rated health, physical activities, smoking status, medication for hypertension, 
medication for diabetes, face to face doctor visits  
b. Reference group 
c. Bold font represents significant 95% CI  
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Table 4.6. Crude and adjusted association between comorbidity profiles and all ABCs 









All three goals 






OR (95% CI) OR (95% CI) OR (95% CI) 
Concordant  0.97  
(0.59 – 1.58) 
1.03  
(0.64 – 1.64) 
1.79  
(0.98 – 3.28) 
Discordant  1.59 
(0.91 – 2.76) 
1.66  
(0.98 – 2.82) 
2.07  
(1.15 – 3.70) 
Both 0.91  
(0.58 – 1.40) 
1.04  
(0.69 – 1.56) 
2.05  
(1.16 – 3.62) 
Noned 1 1 1 
a. Model 1: Unadjusted model 
b.  Model 2: Model 1 and additionally adjusted for Socio-demographic covariates: -  age, gender, 
race/ethnicity, marital status, education status, health-insurance  
c. Model 3: model 2 and additionally adjusted for BMI, self-rated health, physical activity, smoking 
status, medication for hypertension, medication for diabetes, face to face doctor visits 
d. reference groups 







Table 4.7. Results from the final model examining association between comorbidity profiles and ABCs goals achievement, Health and 
Retirement Study, 2010 & 2012 
 
        Variable HDL Cholesterol HbAc1 Blood Pressure 
 
OR (95% Confidence Interval) OR (95% Confidence Interval) OR (95% Confidence Interval) 
Concordant  1.03 (0.64 – 1.66) 1.8 (1.0 – 3.2) 0.9 (0.5 – 1.7) 
Discordant  1.27 (0.77 – 2.11) 2.3 (1.3 – 4.3) 1.2 (0.6 – 2.1) 
Both 1.06 (0.67 – 1.66) 2.1 (1.1 – 3.9) 1.0 (0.6 – 1.8) 
None 1 1 1 




       Female a 1 1 1 




        Non-Hispanic White a 1 1 1 






        Hispanic 1.33 (1.03 – 1.70) 0.74 (0.48 – 1.13) 0.71 (0.53 – 0.93) 
Marital status (%)    
         Married a 1 1 1 
         Not married 0.86 (0.70 – 1.07) 1.06 (0.82 – 1.37) 1.13 (0.91 – 1.39) 
Education (%)    
        Less than high school 0.88 (0.71 – 1.11) 0.91 (0.68 – 1.22) 0.71 (0.54 – 0.95) 
        High school 1.08 (0.81 – 1.44) 0.78 (0.57 – 1.08) 0.70 (0.54 – 0.92) 
        Some college or greater a 1 1 1 
Health insurance (%)    
       Insured a 1 1 1 
      Uninsured 0.82 (0.51 – 1.33) 0.56 (0.39 – 0.82) 0.74 (0.54 – 1.06) 
Physical activity (%)    
        Active a  1 1 1 
        Not active  0.95 (0.78 – 1.17) 0.74 (0.54 – 1.03) 1.03 (0.85 – 1.24) 
Total F2F visits (%)    






      7 -12 per 2 years 0.75 (0.57 – 1.00) 1.00 (0.71 – 1.42) 0.89 (0.69 – 1.14) 
      13-24 per 2 years 0.99 (0.46 – 2.10) 0.75 (0.34 – 1.67) 0.67 (0.38 – 1.19) 
      24+ per 2 years a 1 1 1 
Diabetes medication (%)    
       Insulin 0.93 (0.72 – 1.20) 0.39 (0.26 – 0.60) 1.45 (1.09 – 1.98) 
       Oral 0.54 (0.36 – 0.84) 0.11 (0.07 – 0.18) 1.27 (0.81 - 1.98) 
       Both 0.60 (0.43 – 0.80) 0.12 (0.07 – 0.19) 1.49 (1.09 – 2.03) 
      None a 1 1 1 
BMI (%)    
    Normal a 1 1 1 
    Over weight 0.64 (0.52 – 0.82) 0.59 (0.40 – 0.88) 1.11 (0.78 – 1.58) 
    Obese 0.54 (0.40 – 0.73) 0.72 (0.48 – 1.10) 1.08 (0.80 – 1.46) 
Self-rate health status (%)    
      Poor 0.78 (0.63 – 0.96) 0.74 (0.56 – 0.96) 0.95 (0.77 – 1.18) 
     Good a 1 1 1 






       Yes 0.84 (0.65 – 1.08) 1.13 (0.75 – 1.70) 0.73 (0.55 – 0.96) 
       No a 1 1 1 
 
Abbreviation: BMI, Body mass index; F2F, face to face doctor visit: a. Reference group 
b. OR from final model adjusted for wave, age, gender, race/ethnicity, marital status, education status, health-insurance, BMI, self-rated health, physical 
activity, smoking status, medication for hypertension, medication for diabetes, face to face doctor visits 






We found that, the distribution of comorbidity profiles differed by race/ethnicity. 
Hispanics had the highest percentage of individuals with no chronic condition beside 
diabetes when compared with black and whites. On the other hand, the percentage of 
discordant condition was higher among Hispanics and whites than blacks.  
This study assessed whether there was an association between comorbidity profile 
and cardiometabolic risk factor control among older adults with diabetes. Also, the study 
was examined whether race/ethnicity modified the association between comorbidity 
profile and cardiometabolic risk factor control. Our results show that individual with only 
discordant chronic conditions are more likely to control their HbA1c level than those 
with no chronic condition beside diabetes. Similarly, having both concordant and 
discordant chronic conditions were associated with greater odds of HbA1c control. In 
general, our results suggest that diabetes patient with discordant chronic conditions have 
a better chance to control their HbA1c level than those with no chronic condition beside 
diabetes. Also, we did find race/ethnicity as effect modifier between HDL control and 
comorbidity profile. 
Cardiometabolic risk factor control by both concordant and discordant chronic 
condition 
 
Our result also showed that diabetes patient with both discordant and concordant 
chronic conditions were more likely to control their HbA1c level than patients with no 
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chronic condition beside diabetes. This result is supported by another study, that reported 
that diabetes patients with both concordant and discordant chronic conditions were more 
likely to have better ABCs goals achievement than those of with no chronic condition 
beside daiabetes39. The possible explanation for this result could be a difference in lipid 
lowering medication intake among groups. The literature shows that individual with 
multiple chronic condition or those with polypharmacy were more likely to receive 
statins or other lipid lowering medication as compared to those with no chronic condition 
beside diabetes40.  Further, those taking statins was also related with lowering A1c levels, 
however we were unable to capture satin medication intake in our data. Another 
explanation could be because patients with more chronic conditions had more frequent 
primary and specialty care visits than other patients, which may increase relationship 
between provider and patients. Greater effort by health care providers such as pay 
attention and examine all aspects of the patient conditions, accordingly individualize 
achievement goals and the lifestyle changes help patients to achieved good HbA1c 
control39,41. This suggests that having more chronic condition does not necessarily make 
diabetes patents vulnerable to receiving poorer cardiometabolic risk factor control.  
Cardiometabolic risk factor control by discordant chronic condition  
Our results showed that diabetes patients with only discordant chronic conditions 
was associated with better control of HbA1c level compared with those with no chronic 
condition beside diabetes. This finding did not support our hypothesis that those with 
discordant chronic conditions will have much worse ABCs goals achievement compared 
to those with no chronic condition beside diabetes. However, our result is supported by 
previous literature showing the same impact of discordant chronic conditions on diabetes 
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care. For example, the result from Woodard et al., shows that diabetes patient with only 
discordant chronic conditions were more likely to have better control of glucose and 
lipids than patients with no chronic condition beside diabetes. The possible explanation 
might be that individuals who had much more challenging conditions may receive better 
care with frequent medication and life style changes and do better self-care than 
individuals with no chronic condition beside diabetes. Another explanation could be a 
difference in diabetes medication intake, we found that the prevalence of insulin intake 
was greater among individual with on chronic condition beside diabetes (10%) than 
individual with only discordant chronic condition (5%). This finding was further 
supported by the finding from other literatures, suggested that insulin intake is associated 
with lower HbA1c control7,22.  
However, our result is in contradict with the Pentakota et al.12 study, suggests that 
discordant condition reduced quality of diabetes care.  This inconsistent result may be 
due to the fact the Pentakota study excluded patients with life threatening conditions 
which other study show high risk patients received better provider attention and increased 
a chance to received better care11.  
Cardiometabolic risk factor control by concordant chronic condition  
Our results found no association between having concordant chronic conditions and 
ABCs goal achievements. We found no difference on achieving ABCs goals between 
those who have concordant chronic conditions compared to those with no chronic 
condition. Possible explanation could be attributed to the fact we only included a limited 
number of concordant chronic conditions (n= 3). In addition to that patients with this 
conditions (stroke, hypertension and heart disease)  mostly gives much less attention to 
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goal achievement prioritizations and lifestyle changes than patients who has other 
concordant chronic condition (e.g renal disease & diabetes eye disease) which was not 
capture in our data6. Therefore, it may possible this may buffer the effect of concordant 
chronic conditions on ABCs goals achievement.  However, research has found having 
concordant chronic condition was associated with better ABCs goals achievements13.  
Race/ethnicity does not appear to modify the association between HbA1c control 
and comorbidity profile or blood pressure control and comorbidity profile. A possible 
explanation to our null findings were a small sample size for Hispanic and black 
participants by comorbidity profiles (Hispanic discordant n = 53 and black discordant n = 
37). Furthermore, race/ethnicity modified the association between HDL control and 
comorbidity profiles. We found Hispanics with concordant chronic conditions less likely 
to control their HDL level than Hispanic with no chronic condition (OR: 0.39; 95% CI: 
(0.16 – 0.95)).  
Strengths and Limitations 
The present study has several strengths. First, it uses HRS data, which is a 
nationally representative sample of persons 50 years of age. In addition to the nationally-
representative, multi-stage area probability sample, it over sampled black and Hispanic 
populations to increase generalizability. Second, all outcome variables, blood pressure, 
HDL cholesterol, and HbA1c were from HRS biomarker dataset, which are measured 
objectively. Finally, we assessed association between ABCs goals achievement and 
comorbid chronic condition by using comorbidity profile (concordant and discordant), 
rather than just looing the number of chronic conditions, which ignores a potentially 
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important consideration; whether the comorbidity has similar or opposite management to 
diabetes.  
However, there are several limitations in the present study. The first limitation is, 
the fact that it is a cross-sectional study, it is possible that increased numbers of comorbid 
conditions are the result of, rather than the cause of, poor cardiometabolic risk factor 
control. Therefore, we can only suggest association, not causality.  Second, except for the 
cardiometabolic risk factor variables (BP, HbA1c and HDL), type 2 diabetes and other 
chronic condition were assessed based on self-report information and not verified by 
medical records review. This, make the information less reliable and bias may occur due 
to the misclassification of diabetes and other chronic condition variables. However, study 
suggest that although strength of agreement  varied by conditions, there is good 
agreement between validated evidence of chronic condition and self-report of chronic 
disease42. Fourth, recall bias could weaken the true effect of comorbidity on ABCs goals 
achievements. Fifth, while we examine the effect of comorbidity by their type 
(concordant/ discordant) we looked for presence or absence of condition, and we were 
not able to assess chronic severity level that might influence ABCs goals achievement11. 
Sixth, we included small numbers of common chronic conditions to classify patients into 
comorbid chronic condition groups; however, the condition may not reflect all existing 
chronic conditions and it may lead to underestimating the impact of comorbidity profiles 
in our outcome. Finally, physical activity was poorly measured, and diet was not 
measured. Furthermore, even if the present study adjusted for so many covariant, it is 
plausible to acknowledge that there may be unmeasured confounders (e.g., polypharmacy 
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and diabetes duration and medication adherence) for which we could not make 
adjustments.  
Conclusion  
Our study indicates that diabetes patients with multiple chronic conditions have a 
better or similar ABCs goals achievement compared to individuals with no chronic 
condition beside diabetes, particularly those with discordant chronic conditions regardless 
of race/ethnicity. However, the impact of concordant chronic conditions differed by 
race/ethnicity. Hispanics with concordant chronic conditions were less likely to achieve 
HDL cholesterol goals but no association was found among whites or blacks.  These 
findings suggest the need for strategies that focus on identifying patients who might be at 
high risk of controlling their ABCs goals and the development of interventions that 
account for individuals’ comorbidity profiles and race/ethnicity. Future studies should 
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APPENDIX. A SENSITIVITY ANALYSIS 
 




2010 wave 2012 wave P-value a 
N, Means %, SD N, means %, SD 
 
Exposure (%) 
     
      None 95 6.0 90 5.8 
 
     Concordant  313 18 344 19 
 
     Discordant  127 7 139 10 0.11 
      Both 1,313 68 1,111 64 
 
Outcome (mean, SD)      
    Systolic blood pressure  133.7 21.1 131.8 20.1 0.0075 
    Diastolic blood pressure  79.2 12.3 78 12 0.004 
    HbA1c 6.8 1.5 6.8 1.4 0.89 
     HDL 49.9 14.3 49.6 14.3 0.56 
Covariant       
Age (Mean) years 68.9 10.2 67.6 9.8 0.0024 
Sex (%) 
     
       Female 1034 53 898 51 0.33 
       Male 814 47 786 49 
 
Race/ethnicity (%) 
     
        None Hispanic White 1087 73 934 71 
 
        None Hispanic black 440 14 430 15 0.5 
        Hispanic 321 13 320 14 
 
Marital status (%) 
     
Married  1104 61 1004 61 0.9 






Vigorous physical activity (%) 
     
        Active  721 44 678 45 
 
        Not active  974 56 969 55 0.7 
Diabetes medication (%) 
     
       Insulin 995 54 970 56 
 
       Oral 162 8 148 8 
 
       Both 237 13 247 13 
 
      None 454 25 319 21 0.4 
BMI (%) 
     
    Normal 315 16 262 15 
 
    Over weight 602 17 511 29 
 
    Obese 931 52 911 56 0.24 
Self-rate health status (%) 
     
      Poor 989 51 909 50 
 
     Good 859 49 775 50 0.66 
Health insurance (%) 
     
       Insured 1700 93 1542 92 
 
      Uninsured 141 7 137 8 0.61 
Education (%) 
     
        <high school 560 25 560 29 
 
      High school 562 30 459 26 
 
    >some college 726 45 665 45 0.05 
Blood pressure medication (%) 
     
       Yes 1392 74 1291 74 
 
       No 456 26 393 26 0.96 
 
* P-value represents the comparison of variables between wave 2010 and wave  





Table A.2. Impact of the number of discordant and concordant condition on 
cardiometabolic risk factor control 
 
 
Number of concordant 
Condition 





OR (95% CI) 
 
OR (95% CI) 
 
OR (95% CI) 
Concordant    
0a 1 1 1 
1 - 2   1.29 (0.80 – 2.08) 0.91 (0.66 – 1.25) 0.97 (0.67 – 
1.42) 
3+ 1.16 (0.60 – 2.24) 1.05 (0.68 – 1.62) 0.93 (0.48 – 
1.80) 
Discordant    
0 a 1 1 1 
1-2   1.35 (1.08 – 1.69) 1.06 (0.81 – 1.39) 1.10 (0.80 – 
1.51) 













b Adjusted for wave, age, gender, race/ethnicity, marital status, education status, health insurance, BMI, 
self-rated health, physical activities, smoking status, medication for hypertension, medication for 
diabetes, face to face doctor visits 
a Reference groups 
-Bold font represents significant 95% CI  





Table A.3. The association between comorbidity type and Blood pressure level with cut-




Cut-point=130/80 mmHg Cut-point=140/90mmHg 
OR b 95% CI OR 95% CI 
Concordant  0.89  0.47 - 1.69 0.9  0.5 – 1.7 
Discordant  1.03  0.64 – 1.63 1.2 0.6 – 2.1 
both  1.12 0.65 – 1.93 1.0  0.6 – 1.8 




a Adjusted for wave, age, gender, race/ethnicity, marital status, education status, health insurance, BMI, 
self-rated health, physical activities, smoking status, medication for hypertension, medication for 
diabetes, face to face doctor visits 
b Reference groups 





Table A.4. The association between comorbidity type and HbA1c level with cut-point 7.5 
and 8.0, Health and Retirement Study, 2010 & 2012 
 
 
b Adjusted for wave, age, gender, race/ethnicity, marital status, education status, health insurance, BMI, 
self-rated health, physical activities, smoking status, medication for hypertension, medication for diabetes, 
face to face doctor visits 
a Reference groups 





Cut-point = 8.0 
 









Concordant  1.62  0.77 – 3.41 1.8  1.0 – 3.2 
Discordant  1.73  0.83 – 3.61 2.3 1.3 – 4.3 
both  1.86  0.88 – 3.91 2.1  1.1 – 3.9 
None a 1  1 1 
